aluates Reports

$ 0.0

Automative

Global Cancer Drug based on CAR-T Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-30C6583

Global Cancer Drug based on CAR T Market Insights Forecast to 2028

BUY CHAPTERS

Global Cancer Drug based on CAR-T Market Research Report 2025

Code: QYRE-Auto-30C6583

Report

July 2025

Pages:66

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Fosun Kite Biotechnology

Gilead Sciences

Novartis

Bristol–Myers Squibb

Cancer Drug based on CAR-T Market Size

The global market for Cancer Drug based on CAR-T was valued at US$ 713 million in the year 2024 and is projected to reach a revised size of US$ 998 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Cancer Drug based on CAR-T Market

A type of treatment in which a patient"s T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T cells are taken from a patient’s blood. Then the gene for a special receptor that binds to a certain protein on the patient’s cancer cells is added to the T cells in the laboratory. The special receptor is called a chimeric antigen receptor (CAR). Large numbers of the CAR T cells are grown in the laboratory and given to the patient by infusion. CAR T-cell therapy is used to treat certain blood cancers, and it is being studied in the treatment of other types of cancer. Also called chimeric antigen receptor T-cell therapy.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Cancer Drug based on CAR-T, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Drug based on CAR-T.

The Cancer Drug based on CAR-T market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Drug based on CAR-T market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cancer Drug based on CAR-T companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cancer Drug based on CAR-T Market Report

Report Metric	Details
Report Name	Cancer Drug based on CAR-T Market
Accounted market size in year	US$ 713 million
Forecasted market size in 2031	US$ 998 million
CAGR	5.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Allogeneic Autologous
Segment by Application	Hospital Pharmacy Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Fosun Kite Biotechnology, Gilead Sciences, Novartis, Bristol-Myers Squibb
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Drug based on CAR-T company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Cancer Drug based on CAR-T Market growing?

Ans: The Cancer Drug based on CAR-T Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Cancer Drug based on CAR-T Market size in 2031?

Ans: The Cancer Drug based on CAR-T Market size in 2031 will be US$ 998 million.

Who are the main players in the Cancer Drug based on CAR-T Market report?

Ans: The main players in the Cancer Drug based on CAR-T Market are Fosun Kite Biotechnology, Gilead Sciences, Novartis, Bristol-Myers Squibb

What are the Application segmentation covered in the Cancer Drug based on CAR-T Market report?

Ans: The Applications covered in the Cancer Drug based on CAR-T Market report are Hospital, Pharmacy, Other

What are the Type segmentation covered in the Cancer Drug based on CAR-T Market report?

Ans: The Types covered in the Cancer Drug based on CAR-T Market report are Allogeneic, Autologous

Recommended Reports

CAR-T Therapy

Cell Therapies

Immunotherapy Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cancer Drug based on CAR-T Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Allogeneic

1.2.3 Autologous

1.3 Market by Application

1.3.1 Global Cancer Drug based on CAR-T Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Pharmacy

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cancer Drug based on CAR-T Market Perspective (2020-2031)

2.2 Global Cancer Drug based on CAR-T Growth Trends by Region

2.2.1 Global Cancer Drug based on CAR-T Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Cancer Drug based on CAR-T Historic Market Size by Region (2020-2025)

2.2.3 Cancer Drug based on CAR-T Forecasted Market Size by Region (2026-2031)

2.3 Cancer Drug based on CAR-T Market Dynamics

2.3.1 Cancer Drug based on CAR-T Industry Trends

2.3.2 Cancer Drug based on CAR-T Market Drivers

2.3.3 Cancer Drug based on CAR-T Market Challenges

2.3.4 Cancer Drug based on CAR-T Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cancer Drug based on CAR-T Players by Revenue

3.1.1 Global Top Cancer Drug based on CAR-T Players by Revenue (2020-2025)

3.1.2 Global Cancer Drug based on CAR-T Revenue Market Share by Players (2020-2025)

3.2 Global Cancer Drug based on CAR-T Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Cancer Drug based on CAR-T Revenue

3.4 Global Cancer Drug based on CAR-T Market Concentration Ratio

3.4.1 Global Cancer Drug based on CAR-T Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cancer Drug based on CAR-T Revenue in 2024

3.5 Global Key Players of Cancer Drug based on CAR-T Head office and Area Served

3.6 Global Key Players of Cancer Drug based on CAR-T, Product and Application

3.7 Global Key Players of Cancer Drug based on CAR-T, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Drug based on CAR-T Breakdown Data by Type

4.1 Global Cancer Drug based on CAR-T Historic Market Size by Type (2020-2025)

4.2 Global Cancer Drug based on CAR-T Forecasted Market Size by Type (2026-2031)

5 Cancer Drug based on CAR-T Breakdown Data by Application

5.1 Global Cancer Drug based on CAR-T Historic Market Size by Application (2020-2025)

5.2 Global Cancer Drug based on CAR-T Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Cancer Drug based on CAR-T Market Size (2020-2031)

6.2 North America Cancer Drug based on CAR-T Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Cancer Drug based on CAR-T Market Size by Country (2020-2025)

6.4 North America Cancer Drug based on CAR-T Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cancer Drug based on CAR-T Market Size (2020-2031)

7.2 Europe Cancer Drug based on CAR-T Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Cancer Drug based on CAR-T Market Size by Country (2020-2025)

7.4 Europe Cancer Drug based on CAR-T Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cancer Drug based on CAR-T Market Size (2020-2031)

8.2 Asia-Pacific Cancer Drug based on CAR-T Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Cancer Drug based on CAR-T Market Size by Region (2020-2025)

8.4 Asia-Pacific Cancer Drug based on CAR-T Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cancer Drug based on CAR-T Market Size (2020-2031)

9.2 Latin America Cancer Drug based on CAR-T Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Cancer Drug based on CAR-T Market Size by Country (2020-2025)

9.4 Latin America Cancer Drug based on CAR-T Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cancer Drug based on CAR-T Market Size (2020-2031)

10.2 Middle East & Africa Cancer Drug based on CAR-T Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Cancer Drug based on CAR-T Market Size by Country (2020-2025)

10.4 Middle East & Africa Cancer Drug based on CAR-T Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Fosun Kite Biotechnology

11.1.1 Fosun Kite Biotechnology Company Details

11.1.2 Fosun Kite Biotechnology Business Overview

11.1.3 Fosun Kite Biotechnology Cancer Drug based on CAR-T Introduction

11.1.4 Fosun Kite Biotechnology Revenue in Cancer Drug based on CAR-T Business (2020-2025)

11.1.5 Fosun Kite Biotechnology Recent Development

11.2 Gilead Sciences

11.2.1 Gilead Sciences Company Details

11.2.2 Gilead Sciences Business Overview

11.2.3 Gilead Sciences Cancer Drug based on CAR-T Introduction

11.2.4 Gilead Sciences Revenue in Cancer Drug based on CAR-T Business (2020-2025)

11.2.5 Gilead Sciences Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Cancer Drug based on CAR-T Introduction

11.3.4 Novartis Revenue in Cancer Drug based on CAR-T Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Bristol-Myers Squibb

11.4.1 Bristol-Myers Squibb Company Details

11.4.2 Bristol-Myers Squibb Business Overview

11.4.3 Bristol-Myers Squibb Cancer Drug based on CAR-T Introduction

11.4.4 Bristol-Myers Squibb Revenue in Cancer Drug based on CAR-T Business (2020-2025)

11.4.5 Bristol-Myers Squibb Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Fosun Kite Biotechnology

Gilead Sciences

Novartis

Bristol–Myers Squibb

List of Tables

Table 1. Global Cancer Drug based on CAR-T Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Allogeneic

Table 3. Key Players of Autologous

Table 4. Global Cancer Drug based on CAR-T Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Cancer Drug based on CAR-T Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Cancer Drug based on CAR-T Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Cancer Drug based on CAR-T Market Share by Region (2020-2025)

Table 8. Global Cancer Drug based on CAR-T Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Cancer Drug based on CAR-T Market Share by Region (2026-2031)

Table 10. Cancer Drug based on CAR-T Market Trends

Table 11. Cancer Drug based on CAR-T Market Drivers

Table 12. Cancer Drug based on CAR-T Market Challenges

Table 13. Cancer Drug based on CAR-T Market Restraints

Table 14. Global Cancer Drug based on CAR-T Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Cancer Drug based on CAR-T Market Share by Players (2020-2025)

Table 16. Global Top Cancer Drug based on CAR-T Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Drug based on CAR-T as of 2024)

Table 17. Ranking of Global Top Cancer Drug based on CAR-T Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Cancer Drug based on CAR-T Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Cancer Drug based on CAR-T, Headquarters and Area Served

Table 20. Global Key Players of Cancer Drug based on CAR-T, Product and Application

Table 21. Global Key Players of Cancer Drug based on CAR-T, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Cancer Drug based on CAR-T Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Cancer Drug based on CAR-T Revenue Market Share by Type (2020-2025)

Table 25. Global Cancer Drug based on CAR-T Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Cancer Drug based on CAR-T Revenue Market Share by Type (2026-2031)

Table 27. Global Cancer Drug based on CAR-T Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Cancer Drug based on CAR-T Revenue Market Share by Application (2020-2025)

Table 29. Global Cancer Drug based on CAR-T Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Cancer Drug based on CAR-T Revenue Market Share by Application (2026-2031)

Table 31. North America Cancer Drug based on CAR-T Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Cancer Drug based on CAR-T Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Cancer Drug based on CAR-T Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Cancer Drug based on CAR-T Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Cancer Drug based on CAR-T Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Cancer Drug based on CAR-T Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Cancer Drug based on CAR-T Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Cancer Drug based on CAR-T Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Cancer Drug based on CAR-T Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Cancer Drug based on CAR-T Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Cancer Drug based on CAR-T Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Cancer Drug based on CAR-T Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Cancer Drug based on CAR-T Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Cancer Drug based on CAR-T Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Cancer Drug based on CAR-T Market Size by Country (2026-2031) & (US$ Million)

Table 46. Fosun Kite Biotechnology Company Details

Table 47. Fosun Kite Biotechnology Business Overview

Table 48. Fosun Kite Biotechnology Cancer Drug based on CAR-T Product

Table 49. Fosun Kite Biotechnology Revenue in Cancer Drug based on CAR-T Business (2020-2025) & (US$ Million)

Table 50. Fosun Kite Biotechnology Recent Development

Table 51. Gilead Sciences Company Details

Table 52. Gilead Sciences Business Overview

Table 53. Gilead Sciences Cancer Drug based on CAR-T Product

Table 54. Gilead Sciences Revenue in Cancer Drug based on CAR-T Business (2020-2025) & (US$ Million)

Table 55. Gilead Sciences Recent Development

Table 56. Novartis Company Details

Table 57. Novartis Business Overview

Table 58. Novartis Cancer Drug based on CAR-T Product

Table 59. Novartis Revenue in Cancer Drug based on CAR-T Business (2020-2025) & (US$ Million)

Table 60. Novartis Recent Development

Table 61. Bristol-Myers Squibb Company Details

Table 62. Bristol-Myers Squibb Business Overview

Table 63. Bristol-Myers Squibb Cancer Drug based on CAR-T Product

Table 64. Bristol-Myers Squibb Revenue in Cancer Drug based on CAR-T Business (2020-2025) & (US$ Million)

Table 65. Bristol-Myers Squibb Recent Development

Table 66. Research Programs/Design for This Report

Table 67. Key Data Information from Secondary Sources

Table 68. Key Data Information from Primary Sources

Table 69. Authors List of This Report

List of Figures

Figure 1. Cancer Drug based on CAR-T Picture

Figure 2. Global Cancer Drug based on CAR-T Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Cancer Drug based on CAR-T Market Share by Type: 2024 VS 2031

Figure 4. Allogeneic Features

Figure 5. Autologous Features

Figure 6. Global Cancer Drug based on CAR-T Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Cancer Drug based on CAR-T Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Pharmacy Case Studies

Figure 10. Other Case Studies

Figure 11. Cancer Drug based on CAR-T Report Years Considered

Figure 12. Global Cancer Drug based on CAR-T Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Cancer Drug based on CAR-T Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Cancer Drug based on CAR-T Market Share by Region: 2024 VS 2031

Figure 15. Global Cancer Drug based on CAR-T Market Share by Players in 2024

Figure 16. Global Top Cancer Drug based on CAR-T Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Drug based on CAR-T as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Cancer Drug based on CAR-T Revenue in 2024

Figure 18. North America Cancer Drug based on CAR-T Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Cancer Drug based on CAR-T Market Share by Country (2020-2031)

Figure 20. United States Cancer Drug based on CAR-T Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Cancer Drug based on CAR-T Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Cancer Drug based on CAR-T Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Cancer Drug based on CAR-T Market Share by Country (2020-2031)

Figure 24. Germany Cancer Drug based on CAR-T Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Cancer Drug based on CAR-T Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Cancer Drug based on CAR-T Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Cancer Drug based on CAR-T Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Cancer Drug based on CAR-T Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Cancer Drug based on CAR-T Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Cancer Drug based on CAR-T Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Cancer Drug based on CAR-T Market Share by Region (2020-2031)

Figure 32. China Cancer Drug based on CAR-T Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Cancer Drug based on CAR-T Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Cancer Drug based on CAR-T Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Cancer Drug based on CAR-T Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Cancer Drug based on CAR-T Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Cancer Drug based on CAR-T Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Cancer Drug based on CAR-T Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Cancer Drug based on CAR-T Market Share by Country (2020-2031)

Figure 40. Mexico Cancer Drug based on CAR-T Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Cancer Drug based on CAR-T Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Cancer Drug based on CAR-T Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Cancer Drug based on CAR-T Market Share by Country (2020-2031)

Figure 44. Turkey Cancer Drug based on CAR-T Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Cancer Drug based on CAR-T Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Cancer Drug based on CAR-T Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Fosun Kite Biotechnology Revenue Growth Rate in Cancer Drug based on CAR-T Business (2020-2025)

Figure 48. Gilead Sciences Revenue Growth Rate in Cancer Drug based on CAR-T Business (2020-2025)

Figure 49. Novartis Revenue Growth Rate in Cancer Drug based on CAR-T Business (2020-2025)

Figure 50. Bristol-Myers Squibb Revenue Growth Rate in Cancer Drug based on CAR-T Business (2020-2025)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

CAR T Cell Based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drugs Based on CAR T cell Market Research Report 2025

Global Drug based on CAR T Cell Market Research Report 2025

Global CAR T cell Therapy Drug Market Research Report 2025

Global CAR T Cell Therapy Agents Market Research Report 2025

Global CAR T Cell Therapy Market Research Report 2025

Global CAR T Cell Service Market Research Report 2024

Global CAR T Therapy for Hematological Cancer Market Research Report 2024

Global Autologous CAR T Cell Therapy Market Research Report 2024

Global CAR T Cell Immunotherapy Market Insights Forecast to 2030

Global CD19 targeted CAR T Cell Therapy Market Research Report 2024

Global CAR T Cell Development Service Market Research Report 2024

Global CAR T Cell Manufacturing Service Market Research Report 2024

Global BCMA targeted CAR T Cell Therapy Market Research Report 2025

Global Gene Modifying Immunotherapy for Blood Cancer Market Insights Forecast to 2030

Global T Cell Immunotherapy Market Research Report 2025

Global TCR T Cellular Immunotherapy Market Research Report 2024

Chimeric Antigen Receptor CAR T Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cell Gene Therapy Biomanufacturing Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions